Filenews 8 May 2024
The withdrawal of the Vaxzevria vaccine against Covid-19 was announced by the company AstraZeneca months after admitting in court documents that this preparation could cause rare thrombosis.
According to the company's announcement, the vaccine will no longer be able to be used in the European Union. The request for withdrawal was submitted on March 5 and took effect on Tuesday.
According to AstraZeneca, the vaccine is being withdrawn for commercial reasons as "it has been overtaken by renewed vaccines that tackle the new variants of Covid-19". This, according to the statement, has led to a decline in demand for the AstraZeneca vaccine which is no longer produced or marketed.
"According to independent reports, in the first year of use of this vaccine alone, 6.5 million lives were saved and a total of 3 billion doses were delivered worldwide. Our efforts were recognised by governments around the world and the euro was seen as crucial to ending the global pandemic. We will now work with our legislators and partners to have a clean closure of this chapter and its significant contribution to the Covid-19 pandemic," the company said in a statement.
